Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMASH: Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage
NCT00124150Phase 3Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jun 2002
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing Intravenous magnesium sulfate with Placebo (2 arms). Primary endpoint: Extended Glasgow Outcome Scale at 6 months. Started Jun 2002; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT00124150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00124150.